Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Robert I. Haddad, Lindsay A. Bischoff, Douglas W. Ball, et al.
Journal of the National Comprehensive Cancer Network (2022) Vol. 20, Iss. 8, pp. 925-951
Open Access | Times Cited: 320

Showing 1-25 of 320 citing articles:

The m6A methyltransferase METTL3 drives thyroid cancer progression and lymph node metastasis by targeting LINC00894
Xiang Zhou, Lisha Chang, Qiaoqiao Liang, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 15
Molecular Profiling of 50 734 Bethesda III-VI Thyroid Nodules by ThyroSeq v3: Implications for Personalized Management
Simion I. Chiosea, Steven P. Hodak, Linwah Yip, et al.
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 108, Iss. 11, pp. 2999-3008
Open Access | Times Cited: 31
Spatial transcriptomics reveals prognosis‐associated cellular heterogeneity in the papillary thyroid carcinoma microenvironment
Kai Yan, Qingzhi Liu, Rongrong Huang, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 3
Open Access | Times Cited: 9
Durability of Response With Selpercatinib in Patients With RET-Activated Thyroid Cancer: Long-Term Safety and Efficacy From LIBRETTO-001
Lori J. Wirth, Marcia S. Brose, Vivek Subbiah, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 27, pp. 3187-3195
Open Access | Times Cited: 8
Chinese management guidelines for radioactive iodine-refractory differentiated thyroid cancer (2025 edition)
Yansong Lin, Renfei Wang, Rui Huang, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2025)
Open Access | Times Cited: 1
Sporadic Medullary Thyroid Carcinoma: Towards a Precision Medicine
Antonio Matrone, Carla Gambale, Alessandro Prete, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 33
Molecular Imaging and Theragnostics of Thyroid Cancers
Luca Giovanella, Désirèe Deandreis, Alexis Vrachimis, et al.
Cancers (2022) Vol. 14, Iss. 5, pp. 1272-1272
Open Access | Times Cited: 29
Challenges of Shared Decision-making by Clinicians and Patients With Low-risk Differentiated Thyroid Cancer
Wanding Yang, Ying Ki Lee, Paula Lorgelly, et al.
JAMA Otolaryngology–Head & Neck Surgery (2023) Vol. 149, Iss. 5, pp. 452-452
Closed Access | Times Cited: 17
Current Advances in Radioactive Iodine-Refractory Differentiated Thyroid Cancer
Fabio Volpe, Carmela Nappi, Emilia Zampella, et al.
Current Oncology (2024) Vol. 31, Iss. 7, pp. 3870-3884
Open Access | Times Cited: 6
PD-L1 Expression and Its Modulating Factors in Anaplastic Thyroid Carcinoma
Shipra Agarwal, Chan Kwon Jung, Pranitha Gaddam, et al.
The American Journal of Surgical Pathology (2024) Vol. 48, Iss. 10, pp. 1233-1244
Closed Access | Times Cited: 6
European Society of Endocrine Surgeons (ESES) consensus statement on advanced thyroid cancer: definitions and management
Marco Raffaelli, Nikolaos Voloudakis, Marcin Barczyński, et al.
British journal of surgery (2024) Vol. 111, Iss. 8
Open Access | Times Cited: 6
RAS-Mutated Cytologically Indeterminate Thyroid Nodules: Prevalence of Malignancy and Behavior Under Active Surveillance
Hannah J. Sfreddo, Elizabeth S. Koh, Karena Zhao, et al.
Thyroid (2024)
Closed Access | Times Cited: 5
Molecular Testing for Thyroid Nodules: The Experience at McGill University Teaching Hospitals in Canada
Mohannad Rajab, Richard J. Payne, Véronique‐Isabelle Forest, et al.
Cancers (2022) Vol. 14, Iss. 17, pp. 4140-4140
Open Access | Times Cited: 26
Outcomes of Cytologically Indeterminate Thyroid Nodules Managed With Genomic Sequencing Classifier
Sara Ahmadi, Anupam Kotwal, Athanasios Bikas, et al.
The Journal of Clinical Endocrinology & Metabolism (2024) Vol. 109, Iss. 12, pp. e2231-e2239
Open Access | Times Cited: 5
Current and future of immunotherapy for thyroid cancer based on bibliometrics and clinical trials
Ke Wang, Ying Zhang, Xing Yang, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
An Era of Advances in Systemic Therapies for Advanced Thyroid Cancer
Karen Yun, Ezra E.W. Cohen
JCO Oncology Practice (2024) Vol. 20, Iss. 7, pp. 899-906
Closed Access | Times Cited: 4
The machine learning‐based model for lateral lymph node metastasis of thyroid medullary carcinoma improved the prediction ability of occult metastasis
Xiwei Zhang, Xiaohui Zhao, Lichao Jin, et al.
Cancer Medicine (2024) Vol. 13, Iss. 11
Open Access | Times Cited: 4
Deep learning models for thyroid nodules diagnosis of fine-needle aspiration biopsy: a retrospective, prospective, multicentre study in China
Jue D. Wang, Nafen Zheng, Huan Wan, et al.
The Lancet Digital Health (2024) Vol. 6, Iss. 7, pp. e458-e469
Closed Access | Times Cited: 4
Lobectomy vs Total Thyroidectomy With Ipsilateral Lateral Neck Dissection for N1b Intermediate-Risk Papillary Thyroid Carcinoma
Yoshiyuki Saito, Kenichi Matsuzu, Amr H. Abdelhamid Ahmed, et al.
JAMA Otolaryngology–Head & Neck Surgery (2024)
Open Access | Times Cited: 4
Correlation of SALL1 with CEUS Parameters and Immune Escape in Thyroid Carcinoma
Xia Li, Xu Shuang, Liuwei Hao, et al.
Biomedical Journal (2025), pp. 100829-100829
Open Access
Medullary thyroid cancer in MEN2 pediatric/adolescent carriers of RET mutation: genotype/phenotype correlation and outcome in a retrospective series of 23 patients
Guenda Di Benedetto, Ignazio Barca, Laura De Gregorio, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Long noncoding RNA FAM111A-DT promotes aggressiveness of papillary thyroid cancer via activating NF-κB signaling
Junxin Chen, Yue Chen, Rong Huang, et al.
Journal of Endocrinological Investigation (2025)
Closed Access
Radiofrequency Ablation for Locoregional Structural Incomplete Response in Differentiated Thyroid Cancer: Initial Experience in Greece
George Simeakis, Aikaterini Kapama, Rodis Paparodis, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 255-255
Open Access
Pretreatment level of circulating tumor cells is associated with lymph node metastasis in papillary thyroid carcinoma patients with ≤ 55 years old
Ming Yu, Jiaqin Deng, Yihua Gu, et al.
World Journal of Surgical Oncology (2025) Vol. 23, Iss. 1
Open Access
Correlation analysis of Hashimoto’s thyroiditis with papillary thyroid carcinoma occurrence and its central lymph node metastasis: a single center experience
Kang Sun, Xiaoming Wang, Dexuan Chen, et al.
Frontiers in Endocrinology (2025) Vol. 15
Open Access
Page 1 - Next Page

Scroll to top